V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20065973 | 20086916 | 1.83 | 104.2 | Adjuvant (A) | 2016-06-07 | 2016-06-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | SUNITINIB | 101023012 |
| 20066048 | 20086917 | 1.72 | 46 | Palliative (P) | 2016-04-23 | 2016-05-20 | Carbo F | 02 | N | EVEROLIMUS | 101416618 |
| 20066065 | 20086918 | 1.69 | 70.6 | Palliative (P) | 2019-10-30 | 2019-11-07 | CHOP - 21 days | null | N | HEPATOBLASTOMA SR CISPLATIN | 101436996 |
| 20066294 | 20086920 | 1.68 | 81.8 | Palliative (P) | 2018-12-25 | 2019-01-02 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | CRIZOTINIB | 101184154 |
| 20066336 | 20086921 | null | 74.2 | null | 2019-08-26 | 2019-09-03 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | Y | GEMCARBO | 100683337 |
| 20066495 | 20086923 | 1.74 | 94.5 | Palliative (P) | 2019-03-10 | 2019-03-10 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | SCOPE2 TRIAL | 101230888 |
| 20066525 | 20086924 | 1.72 | 59.4 | null | 2018-02-13 | 2018-03-24 | CISPLATIN + VINORELBINE | N | N | IRINOTECAN | 101677664 |
| 20066571 | 20086925 | 1.74 | 66 | Adjuvant (A) | 2020-06-14 | 2020-07-11 | Bevacizumab + Capecitabine | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100904687 |
| 20066603 | 20086926 | 1.77 | 66.6 | Palliative (P) | 2017-06-13 | 2017-07-05 | PANTHER TRIAL | N | N | CARBOPLATIN + RT | 100446098 |
| 20066628 | 20086928 | 1.63 | 76 | 03 | 2017-05-21 | 2017-06-19 | GO2 TRIAL | N | N | CISPLATIN + TEYSUNO | 101383090 |
| 20066782 | 20086929 | 1.6 | 72.4 | Adjuvant (A) | 2018-07-30 | 2018-08-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | EVEROLIMUS | 100231068 |
| 20066853 | 20086930 | 0 | 51 | 03 | 2017-11-20 | 2017-11-28 | FCarboSt | 02 | N | ECARBOX | 100569725 |
| 20066854 | 20086931 | 1.69 | 72 | Palliative (P) | 2018-04-13 | 2018-04-16 | CAP + RT | 2 | N | CARBOPLATIN + FLUOROURACIL | 100535303 |
| 20066968 | 20086932 | 1.75 | 65.6 | Palliative (P) | 2017-06-02 | 2017-06-25 | SCOPE 2 TRIAL | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100821697 |
| 20067041 | 20086933 | 1.72 | 56.1 | 03 | 2016-04-30 | 2016-05-01 | BORTEZOMIB + THALIDOMIDE | 2 | N | SCOPE2 TRIAL | 100907537 |
| 20067042 | 20086934 | 1.65 | 67 | Adjuvant (A) | 2020-01-18 | 2020-01-24 | Rituximab | 01 | Y | ARISTOTLE TRIAL | 101414422 |
| 20067066 | 20086936 | 0 | 0 | 03 | 2017-09-15 | 2017-09-21 | Carboplatin+Fluorouracil 4 or 5 day | N | N | CAPECITABINE + DOCETAXEL | 100939575 |
| 20067069 | 20086937 | 1.65 | 43.2 | Adjuvant (A) | 2019-11-22 | 2019-11-29 | EOF | 02 | N | ABIRATERONE | 100962822 |
| 20067157 | 20086938 | 1.69 | 72.1 | Curative (C) | 2018-05-06 | 2018-05-06 | Rituximab | 02 | N | NEO-AEGIS TRIAL | 100656938 |
| 20067237 | 20086940 | 1.47 | 97.3 | 03 | 2016-12-10 | 2016-12-24 | Cape +Cetuximab +Oxalip (3 wk) Load | 01 | N | CISPLATIN + VINORELBINE | 101838553 |
| 20067530 | 20086942 | 1.52 | 69 | null | 2016-07-26 | 2016-08-18 | Rituximab | N | N | SCOPE2 TRIAL | 100004687 |
| 20067646 | 20086944 | null | 81.6 | Palliative (P) | 2017-07-11 | 2017-07-20 | Acalabrutinib | N | N | ACELARATE TRIAL | 101556679 |
| 20067725 | 20086945 | 1.62 | 68 | Palliative (P) | null | 2019-08-04 | null | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101610468 |
| 20067809 | 20086946 | 1.68 | 69.9 | Palliative (P) | 2015-04-03 | 2015-05-01 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 02 | N | CISPLATIN + ETOPOSIDE + RT | 101367446 |
| 20067881 | 20086947 | 1.76 | 78.8 | Palliative (P) | 2017-03-06 | 2017-03-24 | EOF | 02 | N | ABIRATERONE | 101365716 |
| 20067942 | 20086948 | 1.75 | 105.7 | Palliative (P) | 2020-11-10 | 2020-12-06 | NEO-AEGIS TRIAL | 01 | null | CAPECITABINE + CISPLATIN + MITOMYCIN | 101215072 |
| 20067991 | 20086949 | 1.76 | 65 | Palliative (P) | 2016-04-29 | 2016-05-13 | CHOP R | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100025544 |
| 20068071 | 20086950 | 1.46 | 60.2 | null | 2019-09-06 | 2019-10-08 | ECarboX | 01 | Y | DOCETAXEL | 101572306 |
| 20068083 | 20086951 | null | null | Palliative (P) | 2019-10-04 | 2019-10-11 | CAPECITABINE + OXALIPLATIN + RT | 01 | N | PACLITAXEL | 100227267 |
| 20068119 | 20086952 | 1.6 | 60.3 | null | 2017-08-04 | 2017-08-05 | INTERAACT trial | 02 | N | CAP + RT | 100748729 |
| 20068143 | 20086953 | 1.59 | 102.1 | Palliative (P) | 2019-05-10 | 2019-05-22 | IRINOTECAN + MDG + PANITUMUMAB | null | N | GEMCITABINE + OXALIPLATIN | 101311949 |
| 20068190 | 20086954 | 1.68 | 73.7 | Adjuvant (A) | 2019-07-12 | 2019-07-12 | DOXORUBICIN | 02 | N | BRIGATINIB | 100553853 |
| 20068282 | 20086955 | 1.8 | 56 | Neo-adjuvant (N) | 2018-05-13 | 2018-06-03 | EVEROLIMUS | 02 | N | ECARBOX | 101332822 |
| 20068475 | 20086956 | 1.7 | 62.7 | 03 | 2017-03-01 | 2017-03-01 | null | 02 | N | IRINOTECAN | 101315951 |
| 20068492 | 20086957 | 1.57 | 76 | 03 | 2019-04-07 | 2019-04-11 | CTD | null | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100033086 |
| 20068503 | 20086958 | 0 | 0 | Palliative (P) | 2019-11-22 | 2019-11-25 | LENALIDOMIDE | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100285838 |
| 20068539 | 20086959 | 1.56 | 100 | Palliative (P) | 2018-12-21 | 2019-01-26 | PEMBROLIZUMAB | 02 | N | ARISTOTLE TRIAL | 101594538 |
| 20068545 | 20086960 | 1.01 | 59.8 | Palliative (P) | 2017-12-27 | 2018-01-15 | Paclitaxel albumin (Abraxane) 21day | 02 | N | CETUXIMAB + RT | 101533586 |
| 20068553 | 20086961 | 1.79 | 61.3 | Curative (C) | null | 2019-07-09 | NEO-AEGIS TRIAL | 99 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100200149 |
| 20068561 | 20086962 | 1.59 | 69.6 | null | 2020-01-13 | 2020-01-16 | PLATO Trials | 01 | Y | PLATO TRIAL | 100226390 |
| 20068681 | 20086963 | 1.77 | 88 | 03 | 2017-12-24 | 2018-01-22 | PLATO Trials | 02 | N | PLATO TRIAL | 100647913 |
| 20068741 | 20086964 | 1.7 | 51.4 | 03 | 2016-03-10 | 2016-03-24 | FCarboSt | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101299960 |
| 20068775 | 20086965 | 1.6 | 67.4 | Palliative (P) | 2018-02-01 | 2018-02-19 | Gemcitabine + Paclitaxel | 02 | N | CARBOPLATIN + VINORELBINE | 101559525 |
| 20068881 | 20086966 | 1.55 | 56.8 | Palliative (P) | 2022-03-11 | 2022-04-10 | null | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100646916 |
| 20069008 | 20086967 | 1.56 | 82.2 | null | 2018-06-20 | 2018-07-10 | ECarboX | N | N | BALLAD TRIAL | 101602400 |
| 20069099 | 20086968 | 0 | 0 | null | 2018-06-08 | 2018-06-10 | Irinotecan | 02 | N | SUNITINIB | 101047299 |
| 20069113 | 20086969 | 1.62 | 72.8 | 03 | 2016-11-26 | 2016-12-15 | null | 01 | N | HYDROXYCARBAMIDE | 100819872 |
| 20069155 | 20086970 | 1.8 | 88 | 03 | 2018-06-15 | 2018-06-15 | DARATUMUMAB | 01 | N | ECARBOX | 101117936 |
| 20069198 | 20086971 | 0 | 0 | Palliative (P) | 2018-12-27 | 2019-01-08 | Docetaxel | 02 | N | FOXTROT TRIAL | 100278818 |
| 20069324 | 20086972 | 1.63 | 74.2 | Palliative (P) | 2019-02-19 | 2019-02-19 | FCiSt | 2 | null | ACTICCA-1 TRIAL | 100851664 |